首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Azepinone-Containing Tetrapeptide Analogues of MelanotropinLead to Selective hMC4R Agonists and hMC5R Antagonist
【2h】

Azepinone-Containing Tetrapeptide Analogues of MelanotropinLead to Selective hMC4R Agonists and hMC5R Antagonist

机译:褪黑激素的含庚酮的四肽类似物导致选择性的hMC4R激动剂和hMC5R拮抗剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To address the need for highly potent, metabolically stable, and selective agonists, antagonists, and inverse agonists at the melanocortin receptor subtypes, conformationally constrained indolo- and benzazepinone residues were inserted into the α-MSH pharmacophore, His6-Phe7-Arg8-Trp9-domain. Replacement of His6 by an aminoindoloazepinone (Aia) or aminobenzazepinone (Aba) moiety led to hMC4R and hMC5R selective agonist and antagonist ligands, respectively (tetrapeptides >1 to >3 and >4, respectively). In peptides >1 to >3 and depending on the para-substituent of the d-Phe residue in position 2, the activity goes from allosteric partial agonism (>1, R = H) to allosteric full agonism (>2, R = F) and finally allosteric partial agonism (>3, R = Br).
机译:为了解决对黑皮质素受体亚型的高效,代谢稳定和选择性激动剂,拮抗剂和反向激动剂的需求,将构象受限的吲哚和苯并ze庚酮残基插入α-MSH药效团His 6 -Phe 7 -Arg 8 -Trp 9 域。用氨基吲哚并ze庚酮(Aia)或氨基苯并ze庚酮(Aba)部分取代His 6 分别导致hMC4R和hMC5R选择性激动剂和拮抗剂配体(四肽> 1 至> 3 和> 4 )。在肽段> 1 至> 3 中,取决于位置2的d-Phe残基的对位取代,其活性来自变构部分激动作用(> 1 ,R = H)变构完全激动(> 2 ,R = F),最后是变构部分激动(> 3 ,R = Br)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号